Managing sleep and sleep disorders in the workforce | Mercer

Webcasts

Well rested and alert: Managing sleep and sleep disorders in the workforce

Recorded: 16 November 2016

  • Overview
    • Did you know that more than 40 million Americans suffer from a sleep disorder with widespread impact on employer costs? Not only is Obstructive Sleep Apnea (OSA) the second most expensive chronic condition in the U.S., but insufficient sleep also has a direct impact on chronic conditions like obesity, diabetes, cardiovascular disease, and depression.

      Workplace losses, including accidents and OSA-related absences are estimated to cost $35B each year, according to a study conducted by Harvard Medical School. Sleep disorders, however, are treatable and preventable.

      Join Health and Benefits consultants from Mercer and sleep experts from SleepMed, Inc., for a webcast sharing the latest research on sleep and sleep disorders, including treatment, and strategies your organization can use to reduce costs and improve employee health outcomes.

  • Why attend
    • By attending this webcast, you will learn:

      • The health and productivity gains of healthy sleep – just 1 extra hour of sleep a night can translate into almost 5% higher earnings due to increased productivity 
      • The impact of sleep disorders on your employees and bottom line, including the consequences of high cost conditions such obesity, diabetes, cardiovascular disease and depression 
      • Why medical advances have improved sleep disorder treatment, but aren’t always used 
      • The latest solutions employers can use to identify, assess, and treat a broad range of sleep related issues  
  • Who should attend
    • Human resources, health and benefits, and wellness leaders at large organizations with 3,000+ employees.

  • Speakers
    • Josh Dunsby, PhD, Principal, Mercer
      Sandra Kuhn, LCSW, Principal, Mercer
      Alyssa Cairns, PhD, Research Scientist, Sleep Med, Inc.
      Richard Bogan, MD, Sleep Med, Inc.
      Mark Miles, Sleep Med, Inc.